-
Lung Cancer Frontline丨Dr. Cho Discusses the Impact of the CHRYSALIS-2 Cohort C Study on the Treatment of Atypical EGFR-Mutant Lung Cancer
The CHRYSALIS-2 study (NCT04077463) Cohort C investigated the combination of amivantamab and lazertinib for the treatment of patients with atypical EGFR-mutant non-small cell lung cancer (NSCLC). The study enrolled patients with various EGFR mutations who were either treatment-naive or had received limited prior treatment. The results demonstrated that the amivantamab+lazertinib combination showed promising antitumor activity,…
-
International Lung Cancer Academic Conference | Dr. Chunxue Bai: Lung Cancer Screening and Management in the Metaverse Era
In 2022, Dr. Chunxue Bai from Fudan University Shanghai Cancer Center, introduced the concept of “Metaverse Medicine,” aiming to leverage metaverse technology to revolutionize disease prevention and treatment. At the 2024 International Lung Cancer Academic Conference, Professor Bai presented a report titled “Lung Cancer Screening and Management in the Metaverse Era.” This article provides a…
-
Balancing Standardization and Innovation: Dr. Jin Li Shares Conference Highlights and the Future of AI in Clinical Research
The “2024 CSCO Digestive Tract Tumor Standardized Treatment Workshop,” co-hosted by the Chinese Society of Clinical Oncology, Beijing Xisike Clinical Oncology Research Foundation, and Hangzhou Oriental Clinical Oncology Research Center, was held in Shanghai from August 17-18, 2024. This workshop featured diverse learning methods, including lectures, discussions, and live surgical demonstrations, aimed at improving the…
-
In-Depth Analysis of UTUC MDT Diagnosis, Radiotherapy, and Translational Development, Pioneering the Path Forward with CUDA-UTUC
From August 8 to 11, 2024, the Annual Meeting of the Urological Surgeons Branch of the Chinese Medical Association (CUDA) was held in Xi’an. The conference was hosted by the Chinese Medical Association and the CUDA Urological Surgeons Branch, with the Air Force Medical University Xijing Hospital as the organizer and the Shaanxi Provincial Medical…
-
Hepatology丨Chinese Researchers Confirm that the EAT-Lancet Diet Significantly Reduces the Risk of Metabolic-Associated Fatty Liver Disease
Editor’s Note With the global rise in obesity, diabetes, and metabolic syndrome, the prevalence of metabolic-associated fatty liver disease (MASLD) is also increasing. Statistics show that MASLD has become one…
-
New Strategies for Bacterial STI Prevention: The CDC Officially Incorporates Doxy PEP into Guidelines
Editor’s Note: Recently, the U.S. Centers for Disease Control and Prevention (CDC) released an important clinical guideline offering new guidance on the prevention of bacterial sexually transmitted infections (STIs). The…
-
IDWeek丨Cutting-Edge Progress in HIV Prevention and Treatment: New Drugs and Innovative Diagnostic Technologies
Editor’s Note: The Infectious Diseases Week (IDWeek) is a premier global academic event in the field of infectious diseases, attracting nearly ten thousand experts and scholars annually to share the…
-
Gut丨HBcrAg Levels Can Predict Chronic Hepatitis B Patients’ Response to Interferon Therapy
Editor’s Note The current treatment options for chronic hepatitis B (CHB) primarily include long-term nucleos(t)ide analogs (NA) therapy and short-term interferon therapy. Although these approaches can control viral replication to…
Connecting Medical Expertise through Media